Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108794412B details a high-yield base-promoted cyclization for triazoles, offering significant cost reduction in API manufacturing and superior purity profiles.
Patent CN113121472A reveals a room-temperature gold catalysis method for N-sulfonyl pyrrolidines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN114920707B reveals a novel iodine-promoted route using DMF as a carbon source for high-purity triazole intermediates, offering significant cost and supply chain advantages.
Patent CN114195711B reveals a novel Pd-catalyzed carbonylation route for quinoline-4(1H)-one. This method offers significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel Te/I catalyzed one-step synthesis of 2-trifluoromethyl oxazoles. High purity pharma intermediates with reduced steps and cost-effective manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN109384753B discloses a catalyst-free rearrangement for 2-phenyl-3-methylbenzofurans, offering a greener, cost-effective route for pharmaceutical intermediates.
Efficient Mn-catalyzed cyclization method for complex heterocycles. High yield, green chemistry, scalable production for pharma intermediates.
Patent CN109400518B discloses a novel iodine-catalyzed one-pot synthesis of 6-arylbenzo[a]carbazoles. This method offers significant cost reduction and supply chain reliability for optoelectronic manufacturers.
Patent CN114751883B reveals efficient Pd-catalyzed carbonylation. Delivers high-purity benzofuran-3-carboxamide with supply chain stability.
Novel metal-free route for trifluoromethyl pyrazoles. Reduces cost and improves supply chain reliability for pharma intermediates. Efficient room temperature reaction.
Novel Pd-catalyzed carbonylation method for quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Novel heating-promoted synthesis eliminates metal catalysts for 2-trifluoromethyl quinoline. Offers green chemistry benefits and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN112299946B reveals iron-catalyzed olefin synthesis offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN114920707B reveals a novel DMF-based synthesis for 3-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and simplified supply chains.
Novel Pd-catalyzed carbonylation route for 2-CF3 quinazolinones using solid CO sources. Enhances purity and safety for API manufacturing supply chains.
Patent CN105732631A reveals efficient N9 vinyl purine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with high yield and scalability.